2012 

WELBIO launches a 2nd call for projects.

17/02/2012 – WELBIO will launch, on 27 February 2012, a 2nd call for projects in fundamental research in life sciences in domains that may lead to medical, pharmaceutical and/or veterinary biotechnology applications. The deadline for the letter of intent submission is 30th March 2012.  Read more...

External call for projects: Clinical validation of cancer biomarkers

The Foundation Fournier-Majoie launched its 6th call for projects aiming at clinical validation of cancer biomarkers.  Those projects should start from an achieved research phase and are thus downstream to projects eligible by WELBIO.  The deadline for project submission is 31th March 2012.  Read more...

Emile Van Schaftingen (UCL) is the recipient of the 2011-2012 Chaire Francqui.

15/02/2012 – This cycle of conferences will focus on intermediate metabolism in the post-genomic era and will take place at the Facultés Universitaires Notre-Dame de la Paix de Namur.  Read more... 

 

Cédric Blanpain (ULB), recipient of the 2012 International Society for Stem Cells Research Award.

12/01/2012 - Cédric Blanpain is the recipient of the 2012 ISSCR Award (International Society for Stem Cells Research) in recognition of his work on understanding stem cells and cancer. For the first time, this prestigious award was given to a scientist in Europe. Read more...

2011

Pierre Maquet (ULg), laureate of the 2011 Pierre and Simone Clerdent Foundation Prize

13/12/2011 – This prize will enable Dr Pierre Maquet's team to carry out a double study on the evolution of cognitive capacities and the functioning of the human brain when individuals are subjected to long periods of sleep deprivation or deficit. Read more...  

A new role for Vascular Endothelial Growth Factor (VEGF) in regulating skin cancer stem cells.  

In a study published in Nature, researchers identify a new role for Vascular Endothelial Growth Factor (VEGF) in regulating skin cancer stem cells. The study was lead by Cédric Blanpain, WELBIO investigator at Université Libre de Bruxelles, in collaboration with the groups of Peter Carmeliet (VIB/K.U.Leuven) and Jody J. Haigh (VIB/UGent). The results can have important implications for the prevention and treatment of different epithelial cancers.  Read more...

Two distinct types of stem cells contribute to mammary gland development and maintenance.

10/10/2011 -  In a study published in Nature, researchers lead by Cédric Blanpain, MD/PhD, WELBIO investigator at the IRIBHM, Université Libre de Bruxelles, Belgium,identify novel classes of breast stem cells that ensure the development and expansion of the different cell lineages of the mammary gland during pregnancy.  Read more...

Pierre Vanderhaeghen (ULB), laureate of the 2011 Francqui Price.

Pierre Vanderhaeghen is rewarded for his seminal contributions to our understanding of brain development and evolution.  His work opens new directions for research on neurological diseases, which are funded by WELBIO.  Read more... 

The annual report 2010 is available.

30/05/2011 - A pdf version is available for downloading.

Dr. Cho from Harvard Medical School recently joined the laboratory of  Dr. Collet, WELBIO principal investigator.

 01/03/2011 - Dr Seung-Hyun Cho recently joined the laboratory of Dr. Jean-François Collet, WELBIO principal investigator (de Duve Institute, Université catholique de Louvain). Read more…

15 research programmes awarded funding as the outcome of the first call for projects.

01/02/2011 – The 15 research programmes, selected as the outcome of the first call for projects, started on February 1st, 2011.  Read more...

First call for projects launched in spring 2010.

23/04/2010 - More than 85 applications were received in response to the first call for projects launched in spring 2010. Read more...